Last 48 quarters of trend data · Healthcare · Medical - Diagnostics & Research
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 45.73 | 32.07 | 39.88 | 31.30 | 34.07 | 36.39 | 64.55 | 38.99 | 38.52 | 61.48 | 51.20 | 43.06 | 39.89 | 36.41 | 35.69 | 28.79 | 19.87 | 27.26 | 25.42 | 28.35 | 30.51 |
| — | -11.9% | -38.2% | -19.7% | -11.6% | -40.8% | +26.1% | -9.4% | -3.4% | +68.9% | +43.4% | +49.5% | +100.7% | +33.6% | +40.4% | +1.6% | -34.9% | -37.3% | +0.4% | +30.2% | +2.9% | |
| P/S Ratio | 6.60 | 6.05 | 5.54 | 5.42 | 5.95 | 5.45 | 6.02 | 6.46 | 6.47 | 8.66 | 8.07 | 8.06 | 6.74 | 7.29 | 5.53 | 6.92 | 6.15 | 5.51 | 5.43 | 6.20 | 6.61 |
| — | +11.1% | -8.0% | -16.1% | -8.0% | -37.1% | -25.4% | -19.9% | -4.0% | +18.8% | +45.9% | +16.5% | +9.6% | +32.4% | +1.9% | +11.6% | -6.9% | -18.3% | -12.3% | +16.0% | +25.2% | |
| P/B Ratio | 3.12 | 2.96 | 2.64 | 2.44 | 3.10 | 2.58 | 2.73 | 2.92 | 3.42 | 3.92 | 3.72 | 3.50 | 3.23 | 3.13 | 3.06 | 3.20 | 3.50 | 3.59 | 3.61 | 4.11 | 4.77 |
| — | +14.6% | -3.4% | -16.4% | -9.3% | -34.0% | -26.5% | -16.6% | +5.8% | +25.1% | +21.4% | +9.3% | -7.9% | -12.9% | -15.2% | -22.2% | -26.5% | -19.9% | -13.6% | +13.4% | +32.9% | |
| P/FCF | 30.81 | 24.32 | 27.44 | 29.75 | 23.30 | 24.07 | 32.79 | 35.19 | 28.15 | 41.34 | 41.04 | 32.28 | 35.46 | 31.38 | 24.99 | 24.63 | 19.83 | 24.35 | 24.70 | 27.75 | 28.14 |
| — | +1.0% | -16.3% | -15.5% | -17.2% | -41.8% | -20.1% | +9.0% | -20.6% | +31.7% | +64.2% | +31.1% | +78.8% | +28.8% | +1.2% | -11.3% | -29.5% | -14.2% | +0.3% | +22.6% | +50.3% | |
| EV / EBITDA | 23.19 | 35.41 | 22.54 | 23.08 | 20.77 | 20.73 | 21.98 | 21.98 | 19.68 | 35.04 | 28.79 | 26.23 | 24.42 | 26.12 | 21.45 | 21.72 | 19.22 | 17.90 | 16.72 | 19.07 | 21.53 |
| — | +70.8% | +2.5% | +5.0% | +5.5% | -40.8% | -23.6% | -16.2% | -19.4% | +34.1% | +34.2% | +20.8% | +27.0% | +46.0% | +28.3% | +13.9% | -10.7% | -19.1% | -11.8% | +19.2% | +14.4% | |
| EV / EBIT | 34.23 | 35.41 | 33.97 | 27.33 | 30.91 | 32.21 | 54.60 | 34.13 | 33.48 | 51.01 | 43.84 | 37.27 | 35.36 | 35.93 | 29.27 | 28.04 | 24.24 | 23.18 | 21.75 | 24.24 | 27.55 |
| — | +10.0% | -37.8% | -19.9% | -7.7% | -36.9% | +24.5% | -8.4% | -5.3% | +42.0% | +49.8% | +32.9% | +45.9% | +55.0% | +34.6% | +15.7% | -12.0% | -37.7% | -4.5% | +29.3% | +12.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.9% | 58.5% | 57.6% | 60.3% | 58.0% | 58.2% | 66.6% | 61.2% | 59.5% | 58.7% | 59.7% | 60.2% | 59.0% | 58.2% | 56.5% | 61.6% | 59.2% | 59.8% | 60.9% | 61.2% | 60.7% |
| — | +0.6% | -13.5% | -1.3% | -2.5% | -0.8% | +11.6% | +1.7% | +0.8% | +0.7% | +5.7% | -2.3% | -0.4% | -2.7% | -7.3% | +0.6% | -2.4% | -0.8% | -0.0% | -1.3% | +3.7% | |
| Operating Margin | 20.9% | 19.0% | 18.0% | 22.6% | 22.0% | 19.1% | 20.1% | 22.2% | 26.7% | 16.5% | 20.3% | 22.6% | 22.1% | 21.1% | 20.0% | 25.5% | 28.0% | 26.3% | 28.4% | 28.3% | 26.4% |
| — | -0.4% | -10.4% | +1.8% | -17.7% | +15.4% | -1.3% | -2.0% | +21.0% | -21.6% | +1.9% | -11.2% | -21.1% | -19.9% | -29.8% | -9.7% | +5.9% | +0.9% | +2.4% | -3.5% | +11.6% | |
| Net Margin | 14.7% | 18.8% | 13.9% | 17.3% | 17.5% | 15.0% | 9.3% | 16.6% | 16.6% | 14.1% | 15.8% | 18.8% | 16.8% | 20.1% | 15.5% | 24.4% | 31.3% | 20.5% | 21.7% | 22.4% | 21.9% |
| — | +25.6% | +48.5% | +4.1% | +5.4% | +6.3% | -40.8% | -11.5% | -1.4% | -29.7% | +2.2% | -23.0% | -46.2% | -2.1% | -28.7% | +8.6% | +42.6% | +28.1% | -12.4% | -9.6% | +19.5% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.1% | 2.3% | 1.6% | 2.0% | 2.3% | 1.8% | 1.1% | 1.9% | 2.2% | 1.6% | 1.8% | 2.0% | 2.0% | 2.2% | 2.1% | 2.9% | 4.6% | 3.4% | 3.6% | 3.8% | 4.0% |
| — | +32.4% | +53.3% | +2.7% | +7.3% | +8.6% | -38.7% | -6.6% | +5.7% | -25.4% | -18.1% | -28.7% | -55.7% | -35.5% | -40.7% | -24.2% | +14.0% | +25.1% | -15.8% | -11.2% | +26.4% | |
| ROA | 4.5% | 1.3% | 1.0% | 1.2% | 1.5% | 1.1% | 0.7% | 1.2% | 1.4% | 1.0% | 1.1% | 1.3% | 1.3% | 1.3% | 1.3% | 1.7% | 2.7% | 1.9% | 2.0% | 2.1% | 2.2% |
| — | +18.3% | +43.2% | +1.2% | +6.7% | +9.4% | -38.3% | -6.0% | +9.6% | -21.4% | -13.9% | -24.3% | -53.6% | -32.3% | -36.0% | -17.3% | +25.1% | +33.8% | -12.6% | -7.8% | +29.6% | |
| ROIC | 5.9% | 1.3% | 1.2% | 1.5% | 1.7% | 1.3% | 1.3% | 1.5% | 2.0% | 1.1% | 1.3% | 1.5% | 1.6% | 1.4% | 1.7% | 1.8% | 2.4% | 2.4% | 2.6% | 2.5% | 2.5% |
| — | -2.9% | -9.6% | +4.7% | -14.4% | +19.5% | -0.2% | -1.6% | +21.9% | -22.7% | -19.7% | -15.5% | -31.7% | -42.9% | -36.2% | -29.9% | -3.9% | +4.0% | -4.6% | -8.4% | +13.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.35 | 0.49 | 0.50 | 0.35 | 0.35 | 0.33 | 0.35 | 0.35 | 0.35 | 0.37 | 0.36 | 0.36 | 0.37 | 0.44 | 0.41 | 0.41 | 0.41 | 0.41 | 0.43 | 0.47 | 0.52 |
| — | +49.6% | +42.5% | +1.0% | +1.3% | -10.1% | -2.9% | -4.1% | -5.3% | -17.0% | -10.0% | -11.3% | -11.3% | +7.9% | -5.8% | -13.5% | -20.1% | -24.6% | -9.9% | -6.3% | -7.6% | |
| Debt / EBITDA | 2.43 | 20.90 | 14.87 | 12.03 | 8.67 | 9.49 | 10.29 | 9.42 | 7.32 | 12.15 | 10.42 | 10.15 | 10.24 | 13.84 | 10.53 | 10.20 | 8.34 | 7.53 | 7.28 | 7.96 | 8.49 |
| — | +120.2% | +44.5% | +27.6% | +18.3% | -21.9% | -1.2% | -7.1% | -28.5% | -12.2% | -1.1% | -0.5% | +22.8% | +83.7% | +44.8% | +28.2% | -1.8% | -22.2% | -9.9% | -1.5% | -19.2% | |
| Current Ratio | 1.87 | 1.63 | 1.65 | 1.87 | 1.87 | 1.52 | 1.62 | 1.43 | 1.40 | 1.37 | 1.43 | 1.85 | 1.68 | 2.26 | 2.08 | 1.89 | 1.89 | 1.78 | 1.75 | 1.68 | 1.43 |
| — | +7.6% | +1.9% | +30.3% | +34.1% | +10.8% | +12.9% | -22.4% | -17.1% | -39.4% | -31.0% | -2.4% | -11.0% | +27.1% | +18.7% | +12.8% | +32.3% | +19.9% | -22.4% | -18.2% | -23.3% | |
| Quick Ratio | 1.51 | 1.29 | 1.25 | 1.52 | 1.51 | 1.10 | 1.22 | 1.05 | 1.05 | 1.01 | 1.04 | 1.51 | 1.37 | 1.94 | 1.70 | 1.51 | 1.56 | 1.38 | 1.32 | 1.27 | 1.09 |
| — | +17.5% | +2.1% | +44.3% | +43.1% | +9.0% | +18.2% | -30.2% | -23.1% | -48.2% | -39.1% | +0.1% | -12.3% | +41.0% | +28.7% | +18.4% | +43.3% | +24.3% | -29.9% | -25.1% | -29.8% | |
| Interest Coverage | 16.97 | 9.39 | 11.07 | 20.60 | 25.96 | 17.06 | 10.23 | 16.68 | 22.56 | 12.23 | 17.66 | 20.55 | 15.49 | 17.39 | 21.78 | 24.08 | 30.15 | 46.98 | 41.57 | 39.87 | 37.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Bull/bear thesis, analyst target revisions, and earnings execution.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DHR stock.
Danaher Corporation's current P/E is 45.7x. The average P/E over the last 4 quarters is 34.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Danaher Corporation's current operating margin is 20.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Danaher Corporation's business trajectory between earnings reports.